Major ovarian cancer clinical study announced at Yale using combination drug therapy, phenoxodiol with docetaxel
29th Nov 2005, 00:15 GMT
A clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combine the anti-cancer drug phenoxodiol with docetaxel for women with recurrent ovarian cancer. "Advanced-stage ovarian cancer is one of the most devastating forms of cancer, with half of the women diagnosed with it dying within five years," said principal investigator Thomas Rutherford, M... click link for more info.
Major ovarian cancer clinical study announced at Yale using combination drug therapy, phenoxodiol with docetaxel related news:
- Major Ovarian Cancer Clinical Study Announced At Yale Using Combination Drug Therapy — ScienceDaily Headlines
- New Clinical Study of Phenoxodiol as Chemo-sensitizer for Docetaxel in Ovarian Cancer Commences at Yale Univ School of Medicine — Operations-Related News from StratCenter.com
- New Clinical Study of Phenoxodiol as Chemo-sensitizer for Docetaxel in Ovarian Cancer Commences at Yale University School of Medicine — PR Newswire: All Releases
- Marshall Edwards initiates trial of chemo-sensitizer — Pharmaceutical Business Review Online
- Ginkgo biloba does more than help with memory — The Cancer Blog
- Distance from radiation therapy facility impacts breast cancer treatment, USA — Medical News Today RSS/XML Feed
- Researchers Discover Molecular Differences Between Low-grade and High-grade Ovarian Cancers — Kansas City infoZine Health Headlines
- New Cell Line Helps Prostate Cancer Study — RedOrbit News - Health
- Combination therapy better for larynx — United Press International - NewsTrack
- NIH Attempts To Develop Ovarian Cancer Screening — NBC 17 - Health
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes